Challenges and pitfalls in clinical trials of treatments for dry eye

Area of Science:

• Ophthalmology
• Clinical Trial Design
• Dry Eye Disease Research

Background:

• Dry eye disease (DED) presents unique challenges for clinical trials.
• Patient-reported symptoms, self-administered palliative treatments, and outcome measurement limitations complicate efficacy evaluation.
• Understanding DED's specific pathophysiology is crucial for trial design.

Purpose of the Study:

• To identify and discuss common pitfalls in recent dry eye disease clinical trials.
• To provide considerations for optimizing clinical trial design in DED research.
• To offer guidance for future dry eye therapy investigations.

Main Methods:

• Review of recent clinical trials in dry eye disease.
• Discussion of DED-specific peculiarities (symptoms, signs, pathophysiology).
• Analysis of general clinical trial challenges (patient selection, randomization, placebo effect) applied to DED.

Main Results:

• Identified numerous challenges in DED clinical trial design and execution.
• Highlighted issues with patient selection, small population randomization, and placebo effect assessment.
• Emphasized the need for careful consideration of inclusion/exclusion criteria and outcome measures, including symptom analysis and ocular surface staining.

Conclusions:

• Conducting robust clinical trials for dry eye disease requires addressing specific disease characteristics and methodological challenges.
• Improved study designs, outcome measures, and consideration of alternative evaluation methods are essential for advancing DED therapy.
• Future research should focus on rigorous trial conduct to yield reliable therapeutic outcome data.